Dror Meirow

Dror Meirow has addressed the critical safety question of ovarian tissue reimplantation in cancer survivors, developing methods to detect and eliminate minimal residual disease in cryopreserved ovarian tissue to prevent cancer reintroduction during transplantation. His work on ovarian tissue autotransplantation has achieved among the highest live birth rates globally for this fertility restoration technique. His research on chemotherapy ovarian toxicity mechanisms has elucidated the pathways through which alkylating agents and other drugs damage ovarian follicles, informing protective strategies.